Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Klyv Therapeutics AS
AS
Active
Org 832316032
Gaustadalléen 21, 0349
Oslo
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2023 · 2 years old
0 employees
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Klyv Therapeutics AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
2M
2M
1M
1M
0M
2023: 0M
0M
2023
2024: 1M
1M
2024
2025: 2M (+100% vs 2024)
2M
+100%
2025
EBITDA
NOK millions
0M
0M
-1M
-1M
-1M
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: -1M
-1M
2025
Income statement
NOK thousands
Item
2025
2024
2023
Revenue
2 207
935
0
Staff expenses
−598
−0
−0
EBITDA
−1 065
161
−0
Depreciation & amort.
−0
−0
−0
EBIT
−1 065
161
−0
Net financials
4
−4
0
Profit before tax
−1 061
158
−0
Tax
−0
35
−0
Net profit
−1 061
123
−0
Balance sheet
NOK thousands
Item
2025
2024
2023
Total assets
7 816
934
94
Equity
6 662
718
94
Long-term debt
0
0
0
Short-term debt
1 154
217
0
Total debt
1 154
217
0
Financial ratios
5-year trend
EBITDA margin
−48,3 %
This company
15,8 %
Market median
This company
Market median
406% below market
2023
2025
Equity ratio
85,2 %
This company
38,2 %
Market median
This company
Market median
123% above market
2023
2025
Return on equity
−15,9 %
This company
18,4 %
Market median
This company
Market median
186% below market
2023
2025
Net profit margin
−48,1 %
This company
8,1 %
Market median
This company
Market median
694% below market
2023
2025
Asset turnover
0,28×
This company
1,12×
Market median
This company
Market median
75% below market
2023
2025
Debt / equity
0,17×
This company
0,62×
Market median
This company
Market median
73% below market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-08-30 – 2023-12-31
View
PDF
More on Klyv Therapeutics AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
